SCHEDULE OF WARRANT ACTIVITY (Details) |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
$ / shares
shares
| |
| Equity [Abstract] | |
| Warrants outstanding, Beginning balance | shares | 17,262,656 |
| Weighted average exercise price outstanding, Beginning balance | $ / shares | $ 1.50 |
| Warrants, Granted | shares | |
| Weighted average exercise price, Granted | $ / shares | |
| Warrants, Forfeited, cancelled | shares | |
| Weighted average exercise price, Forfeited, cancelled | $ / shares | |
| Warrants outstanding, Ending balance | shares | 17,262,656 |
| Weighted average exercise price outstanding, Ending balance | $ / shares | $ 1.50 |
| Warrants, exercisable | shares | 17,262,656 |
| Weighted average exercise price, exercisable | $ / shares | $ 1.50 |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercisable number. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments exercisable weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments forfeited in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments grants in period weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|